Results 191 to 200 of about 60,177 (254)

Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study. [PDF]

J Transl Med
Lisco G, Guido D, Cerabino N, Di Chito M, Donvito R, Bonfiglio C, Shahini E, Zappimbulso M, Randazzo C, Barletta D, Stabile D, Ancona A, Coletta S, Pesole PL, Giannelli G, De Pergola G.   +15 more
europepmc   +1 more source

Dementia with Lewy Bodies (DLB), Parkinson's Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1). [PDF]

ACS Omega
Angelucci F, Nedelska Z, Napravnikova Manová B, Katonová A, Jurášová V, Svetlikova D, Vyhnálek M, Hort J.   +7 more
europepmc   +1 more source

Comment on "Role of increased plasminogen activator inhibitor-1 and vitronectin in gestational diabetes mellitus". [PDF]

Rev Assoc Med Bras (1992)
Yin H, Shi R.
europepmc   +1 more source

Algorithms in Allergy: Hereditary Angioedema

Allergy, Volume 81, Issue 8, Page 3008-3012, August 2026.
Konrad Bork, Markus Magerl, Emel Aygören‐Pürsün, Henriette Farkas   +3 more
wiley   +1 more source

Mechanisms behind elevated serum levels of plasminogen activator inhibitor-1 in frontotemporal lobar degeneration. [PDF]

Neural Regen Res
Angelucci F, Hort J.
europepmc   +1 more source

Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice. [PDF]

PLoS One
Mizukami Y, Kawao N, Ohira T, Okada K, Yamao H, Matsuo O, Kaji H.   +6 more
europepmc   +1 more source

The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction. [PDF]

Front Immunol
Yatsenko T, Rios R, Nogueira T, Salama Y, Takahashi S, Adachi E, Tabe Y, Hattori N, Osada T, Naito T, Takahashi K, Hattori K, Heissig B.   +12 more
europepmc   +1 more source

Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease. [PDF]

BMC Nutr
Farzin L, Mansouri E, Salehi S, Baker E, Amirkhizi F, Asghari S.   +5 more
europepmc   +1 more source

A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence. [PDF]

Cell Commun Signal
Shaikh SB, Balaya RDA, Dagamajalu S, Bhandary YP, Unwalla H, Prasad TSK, Rahman I.   +6 more
europepmc   +1 more source